Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)

ग्रंथसूची विवरण
मुख्य लेखकों:	Bafadhel, M, Sing, D, Jenkins, C, Peterson, S, Bengtsson, T, Fageras, M
स्वरूप:	Conference item
प्रकाशित:	European Respiratory Society 2018

Adding budesonide to formoterol reduces risk of clinically important deteriorations (CID) in moderate to very severe COPD
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2018)

Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2017)

Investigating blood eosinophil count thresholds in patients with COPD
द्वारा: Russell, R, और अन्य
प्रकाशित: (2018)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
द्वारा: Pavord, I, और अन्य
प्रकाशित: (2017)

Case series of long-term macrolide therapy effect on eosinophil count in COPD
द्वारा: Asciak, R, और अन्य
प्रकाशित: (2017)

Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2018)

Blood eosinophil count and exacerbation risk in patients with COPD.
द्वारा: Kerkhof, M, और अन्य
प्रकाशित: (2017)

Characterising non-eosinophilic COPD
द्वारा: Hambleton, K, और अन्य
प्रकाशित: (2015)

Eosinophils in COPD: just another biomarker?
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2017)

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS
द्वारा: Bafadhel M, और अन्य
प्रकाशित: (2022-12-01)

Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
द्वारा: Antonella Casiraghi, और अन्य
प्रकाशित: (2020-03-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
द्वारा: Shrimanker, R, और अन्य
प्रकाशित: (2017)

Variability of blood eosinophil count and prognosis of COPD exacerbations
द्वारा: Sandra Martínez-Gestoso, और अन्य
प्रकाशित: (2021-01-01)

Blood eosinophil count as a prognostic biomarker in COPD
द्वारा: Oh YM, और अन्य
प्रकाशित: (2018-10-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
द्वारा: Lababidi, R, और अन्य
प्रकाशित: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
द्वारा: Djamin, R, और अन्य
प्रकाशित: (2019)

Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis
द्वारा: Antonio Spennacchio, और अन्य
प्रकाशित: (2024-04-01)

Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
द्वारा: Manzetti GM, और अन्य
प्रकाशित: (2023-10-01)

Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD
द्वारा: Tomoki Maetani, और अन्य
प्रकाशित: (2023-10-01)

Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
द्वारा: Shigeo Muro, और अन्य
प्रकाशित: (2021-06-01)

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
द्वारा: Hambleton, K, और अन्य
प्रकाशित: (2016)

Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation
द्वारा: Tzu-Tao Chen, और अन्य
प्रकाशित: (2023-12-01)

Current smoking reduces small airway eosinophil counts in COPD
द्वारा: Augusta Beech, और अन्य
प्रकाशित: (2024-01-01)

Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
द्वारा: Shigeo Muro, और अन्य
प्रकाशित: (2021-08-01)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
द्वारा: Hambleton, K, और अन्य
प्रकाशित: (2017)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
द्वारा: Kerkhof, M, और अन्य
प्रकाशित: (2017)

Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD
द्वारा: Saya Nakamura, और अन्य
प्रकाशित: (2024-10-01)

Identification of COPD Inflammatory Endotypes Using Repeated Sputum Eosinophil Counts
द्वारा: Augusta Beech, और अन्य
प्रकाशित: (2022-10-01)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
द्वारा: Greulich T, और अन्य
प्रकाशित: (2018-09-01)

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
द्वारा: Marjan Kerkhof, और अन्य
प्रकाशित: (2020-11-01)

Budesonide/formoterol combination in COPD: a US perspective
द्वारा: Amir Sharafkhaneh, और अन्य
प्रकाशित: (2010-10-01)

Late breaking abstract - Resistomics of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes
द्वारा: Ramsheh, M, और अन्य
प्रकाशित: (2018)

Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis
द्वारा: Caroline Michèle Andrist, और अन्य
प्रकाशित: (2020-12-01)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
द्वारा: Song JH, और अन्य
प्रकाशित: (2017-08-01)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2016)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
द्वारा: Russell, R, और अन्य
प्रकाशित: (2016)

Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
द्वारा: George, L, और अन्य
प्रकाशित: (2019)

Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization
द्वारा: Bélanger M, और अन्य
प्रकाशित: (2018-10-01)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
द्वारा: Belchamber KBR, और अन्य
प्रकाशित: (2018-09-01)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2014)

Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)

समान संसाधन

समान संसाधन